TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: 0.220nMAssay Description:Displacement of [125I]T3 from recombinant thyroid hormone receptor alpha (unknown origin) expressed in sf9 cells by scintillation proximity assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: 0.330nMAssay Description:Displacement of [125I]3,5,3'-triiodo-L-thyronine from His-tagged human recombinant TRalpha1 by scintillation proximity assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: 2.30nMAssay Description:Displacement of [125I]-T3 from human TRalpha expressed in insect cells after 16 to 48 hrs by gamma-countingMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: 2.33nMAssay Description:Displacement of [125I]T3 from human recombinant thyroid harmone receptor alpha after 16 to 48 hrs by gamma-ray detectionMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.240nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.240nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.240nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.240nMpH: 7.0 T: 2°CAssay Description:IC50 is the concentration of each compound required to inhibit 50% binding of 125I-T3 to hTRalpha. EC50 is the concentration of compound required to ...More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.240nMAssay Description:Inhibitory concentration against cloned human thyroid hormone receptor alpha 1More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:Displacement of [125I]-Triiodothyronine from human recombinant TRalpha1 ligand binding domain after 2 to 3 hrs by beta countingMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKd: 0.0580nMAssay Description:Human thyroid hormone receptor alpha and beta (hTR alpha1) and (hTR beta1) were produced using TNT coupled reticulocyte lysate system from Promega.More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2nMAssay Description:Half-maximum activation of human Thyroid hormone receptor alpha1 (hTRalpha1)More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2nMAssay Description:Effective concentration of the compound binding towards TRalpha in E25B2 cells (agonistic activity)More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKd: 0.0600nMAssay Description:Binding affinity of compound was determined against Thyroid hormone receptor alpha1More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 0.410nMAssay Description:Agonist activity at human thyroid hormone receptor alpha expressed in HEK293 cells by luciferase reporter gene assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2.40nMAssay Description:TRE-driven dual-luciferase reporter assay in human uterine cervical cancer (Hela) cell lineMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2.40nMAssay Description:TRE-driven dual-luciferase reporter assay in human bone osteosarcoma epithelial (U2OS) cell line.More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2.10nMAssay Description:Agonist activity at human recombinant TRalpha1 transfected in CV-1 cells after 8 to 10 hrs by alkaline phosphatase reporter gene assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKd: 0.0580nMAssay Description:Thyroid hormone competitive binding assay using TNT T7 quick-coupled transcription translation system from promega.More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKd: 0.0580nMAssay Description:Displacement of [125I]T3 from human TRalpha receptorMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2.40nMAssay Description:Effect on human TRalpha transactivation activity in HeLa cells by luciferase reporter assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 2.40nMAssay Description:Effect on human TRalpha transactivation activity in U2OS cells by luciferase reporter assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 1.01nMAssay Description:Human epithelial kidney cells (HEK 293) were grown to 80% confluency in Dubelcco's modified Eagles 4.5 g/L glucose medium (high glucose DMEM) con...More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 3.40nMAssay Description:Agonist activity at human THRalpha expressed in CHO cells after 24 hrs by luciferase assayMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 0.5nMAssay Description:Agonist activity at human THRalpha expressed in baculovirus infected SF9 cells after 15 mins by gel electrophoresisMore data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Agonist activity at recombinant His6-tagged THR-alpha (unknown origin) expressed in Escherichia coli BL21(DE3) co-expressing RXR preincubated for 30 ...More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKd: 0.170nMAssay Description:Binding affinity of the compound towards thyroid hormone receptor (hTR alpha 1)More data for this Ligand-Target Pair
TargetThyroid hormone receptor alpha(Homo sapiens (Human))
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Metabasis Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKd: 0.100nMAssay Description:Binding affinity against human Thyroid hormone receptor alpha1 (hTRalpha1) using radiolabeled T3More data for this Ligand-Target Pair